Tianda Pharmaceuticals（00455）“Anti-Epidemic Formula 1” granules approved to sell in Australia (Multi-sources)

08.05.2020

Tianda Pharmaceuticals（00455）announces its “Anti-Epidemic Formula 1” granules has been approved for entry into the Australian Register of Therapeutic Goods as a listed medicine. This will allow the Group to supply and sell Anti-Epidemic Formula 1 in Australia and make the expansion of TCM business. The Anti-Epidemic Formula 1 is a preventive prescription mainly for improving people’s immune system, helping them to prevent influenza or COVID-19.

From late February to early April this year, the Group launched anti-epidemic campaigns in Guangdong, Hong Kong and Macau, among other areas, to provide complimentary TCM consultation and Anti-Epidemic Formula 1 to more than 1,000 individuals. Additionally, over 1,500 doses of Anti-Epidemic Formula 1 have been sold in the Zhuhai TDMall, the Group’s flagship Chinese medicine clinic in Zhuhai.

Source: FINET/ Yahoo Finance/ ASSTOCKS/ LINE TODAY

This is an English translation of the original Chinese text. If there is any inconsistency or ambiguity between the English version and the Chinese version, the Chinese version shall prevail.